(AOF) – Implanet, a medical technology company specializing in implants intended for orthopedic surgery and in the distribution of technological medical equipment, announces the launch of a cash capital increase with maintenance of preferential subscription rights (“DPS” ) from shareholders in the amount of 6.384 million euros through the issue of 97.478 million new shares at a unit price of 0.0655 euros corresponding to the closing price on January 3, 2024.
The objectives of the Capital increase aim in particular to ensure the financing of the company’s anticipated cash flow needs for the next 12 months (the financial resources available to the company, at the date of this press release, do not cover its forecast needs for the next 12 months). 12 months) and meet its financial commitments.
Based on current business assumptions and anticipated commercial developments with Sanyou Medical, the company estimates that the Capital increase operation, up to a minimum amount of 5 million euros, would ensure, once achieved, financial visibility of more than 12 months.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
